XBiotech
XBIT
46 hedge funds and large institutions have $58.4M invested in XBiotech in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 2
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
383% more capital invested
Capital invested by funds: $12.1M → $58.4M (+$46.3M)
44% more funds holding
Funds holding: 32 → 46 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.98M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$2.11M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.94M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
ALPS Advisors
Denver,
Colorado
|
-$342K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$162K |
| 3 |
Citigroup
New York
|
-$24.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18.5K |
XBIT Hedge Fund Activity: Q2 2016 in Review
46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2016, worth a combined $58.4M — up 383% from $12.1M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new XBIT positions and 2 closed out — a net gain of 14 holders — while 24 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.1M. The largest seller was ALPS Advisors, exiting entirely with an estimated $342K sold.
- 46 institutional investors held XBiotech (XBIT) as of Q2 2016, up from 32 in Q1 2016.
- Funds reported $58.4M of XBiotech stock for Q2 2016, up 383% quarter-over-quarter.
- 16 funds opened new XBiotech positions in Q2 2016 and 2 closed out, a net change of +14 holders.
- The largest XBiotech buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $5.1M added.
- The largest XBiotech seller in Q2 2016 was ALPS Advisors, an estimated $342K sold.
Based on aggregated 13F filings for Q2 2016.